Gopal Shameer, Carr Bryan, Nelson Paul
Department of Anaesthesia and Intensive Care Medicine, University Hospital of North Staffordshire NHS Trust, City General Hospital, Stoke-on-Trent, Staffordshire, UK.
Crit Care Med. 2006 Jun;34(6):1805-10. doi: 10.1097/01.CCM.0000217922.75068.EA.
Studies assessing the accuracy of microalbuminuria to predict illness severity on the intensive care unit have produced inconsistent results.
To determine the diagnostic accuracy of microalbuminuria to predict illness severity in critically ill patients on the intensive care unit.
MEDLINE (1951 to September 2004) and EMBASE (1980 to September 2004) electronic databases were searched for relevant studies. Reference lists of all abstracts were manually searched to identify studies not included in the electronic database.
Studies that prospectively evaluated the accuracy of microalbuminuria to predict illness severity and/or mortality probability in adult patients on the intensive care unit were selected.
We included nine studies in the review. Data to evaluate methodological quality and results were abstracted.
The methodological quality of a number of studies was poor. Significant heterogeneity in the design and conduct of the studies circumvented the data being subjected to meta-analysis. Studies also differed in the timing of the index test, in the methods of quantifying microalbuminuria, and in the cutoff values used.
This descriptive analysis reveals that microalbuminuria may hold promise as a predictor of illness severity and mortality on the intensive care unit. However, future epidemiologic studies need to be conducted to determine the optimal timing as well as the threshold reference value for the urine albumin creatinine ratio in the adult intensive care unit population. Thereafter, multiple-center prospective epidemiologic studies must be conducted to confirm and validate the findings of these preliminary studies. Future studies should conform to the Standards for Reporting of Diagnostic Accuracy checklist in terms of study design, conduct, and reporting. Presently there is no evidence to warrant the use of this tool on the intensive care unit.
评估微量白蛋白尿预测重症监护病房疾病严重程度准确性的研究结果并不一致。
确定微量白蛋白尿预测重症监护病房危重症患者疾病严重程度的诊断准确性。
检索MEDLINE(1951年至2004年9月)和EMBASE(1980年至2004年9月)电子数据库中的相关研究。人工检索所有摘要的参考文献列表,以识别未纳入电子数据库的研究。
选择前瞻性评估微量白蛋白尿预测重症监护病房成年患者疾病严重程度和/或死亡概率准确性的研究。
我们在综述中纳入了9项研究。提取用于评估方法学质量和结果的数据。
许多研究的方法学质量较差。研究设计和实施中的显著异质性使得数据无法进行荟萃分析。研究在指标检测时间、微量白蛋白尿定量方法以及所用临界值方面也存在差异。
这项描述性分析表明,微量白蛋白尿可能有望作为重症监护病房疾病严重程度和死亡率的预测指标。然而,需要开展未来的流行病学研究,以确定成人重症监护病房人群尿白蛋白肌酐比值的最佳检测时间以及临界参考值。此后,必须开展多中心前瞻性流行病学研究,以确认和验证这些初步研究的结果。未来的研究应在研究设计、实施和报告方面符合《诊断准确性报告标准》清单。目前没有证据支持在重症监护病房使用该工具。